Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
River Eletec
6666
Forside
2330
(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -4.00%4.85B | -4.00%4.85B | -4.06%4.95B | 5.30%5.08B | 2.01%4.89B | 2.95%5.05B | 2.95%5.05B | 3.81%5.16B | 12.11%4.83B | 230.42%4.79B |
-Cash and cash equivalents | -4.00%4.85B | -4.00%4.85B | -4.06%4.95B | 5.30%5.08B | 2.01%4.89B | 2.95%5.05B | 2.95%5.05B | 3.81%5.16B | 12.11%4.83B | 230.42%4.79B |
Receivables | -4.96%10.38M | -4.96%10.38M | 24.70%20M | -25.12%10.41M | 31.87%11.98M | 14.03%10.92M | 14.03%10.92M | -20.29%16.04M | -93.93%13.91M | -34.18%9.08M |
-Accounts receivable | -4.96%10.38M | -4.96%10.38M | 24.70%20M | -25.12%10.41M | 31.87%11.98M | 14.03%10.92M | 14.03%10.92M | -20.29%16.04M | -93.93%13.91M | -34.18%9.08M |
-Gross accounts receivable | -4.96%10.38M | -4.96%10.38M | 24.70%20M | -25.12%10.41M | 31.87%11.98M | 14.03%10.92M | 14.03%10.92M | -20.29%16.04M | -93.93%13.91M | -34.18%9.08M |
Inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,260.09%8.83M |
Prepaid assets | 19.23%30.26M | 19.23%30.26M | 37.04%36.67M | 58.28%41.08M | 21.12%22.39M | 20.73%25.38M | 20.73%25.38M | 81.18%26.76M | 63.39%25.96M | -16.33%18.48M |
Tax assets-Current | --9.85M | --9.85M | --797K | ---- | 33.58%2.2M | --0 | --0 | ---- | --2.95M | -83.60%1.65M |
Other current assets | 212.69%1.01M | 212.69%1.01M | -8.30%1.05M | -89.13%356K | -99.37%7K | -65.16%323K | -65.16%323K | 18.67%1.14M | 300.24%3.27M | -70.98%1.12M |
Total current assets | -3.68%4.9B | -3.68%4.9B | -3.75%5.01B | 5.37%5.13B | 1.94%4.93B | 3.04%5.09B | 3.04%5.09B | 3.94%5.21B | 7.04%4.87B | 221.93%4.83B |
Non current assets | ||||||||||
Net PPE | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Gross PP&E | --0 | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Total investment | ---- | ---- | 256.77%28.65M | 305.48%32.53M | -3.85%7.88M | ---- | ---- | -0.66%8.03M | 12.40%8.02M | 14.72%8.19M |
Goodwill and other intangible assets | 12.05%8.52M | 12.05%8.52M | -47.32%5.01M | -47.57%5.98M | --7.86M | --7.6M | --7.6M | --9.5M | --11.4M | ---- |
-Other intangible assets | 12.05%8.52M | 12.05%8.52M | ---- | ---- | ---- | --7.6M | --7.6M | ---- | ---- | ---- |
Other non current assets | 212.01%25.15M | 212.01%25.15M | ---- | ---- | ---- | -0.76%8.06M | -0.76%8.06M | --1K | ---- | ---- |
Total non current assets | 114.96%33.67M | 114.96%33.67M | 91.95%33.66M | 98.24%38.51M | 92.10%15.73M | 92.81%15.66M | 92.81%15.66M | 116.91%17.54M | 172.15%19.43M | 14.72%8.19M |
Total assets | -3.31%4.93B | -3.31%4.93B | -3.43%5.05B | 5.74%5.17B | 2.10%4.94B | 3.18%5.1B | 3.18%5.1B | 4.12%5.22B | 7.30%4.89B | 220.94%4.84B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -18.49%67.1M | -18.49%67.1M | -22.15%65.78M | 26.83%76.26M | 37.80%62.7M | 16.79%82.32M | 16.79%82.32M | 19.42%84.5M | -13.64%60.13M | 0.18%45.5M |
-Total tax payable | -95.82%1.21M | -95.82%1.21M | -97.22%907K | 1,299.50%8.47M | -96.20%302K | -25.68%28.97M | -25.68%28.97M | 6.77%32.64M | -96.53%605K | --7.96M |
-Other payable | 23.50%65.89M | 23.50%65.89M | 25.09%64.87M | 13.90%67.8M | 66.20%62.39M | 69.35%53.35M | 69.35%53.35M | 29.04%51.86M | 14.03%59.53M | -17.34%37.54M |
Accrued and deferred income | 87.39%239.5M | 87.39%239.5M | 75.15%232.86M | 93.75%237.09M | 2,827.80%124.61M | 1,980.22%127.81M | 1,980.22%127.81M | 2,557.88%132.95M | 4,657.78%122.37M | 8.88%4.26M |
Other current liabilities | 1.71%14.8M | 1.71%14.8M | 13.02%15.38M | 36.86%11.46M | -10.93%11.34M | 31.51%14.55M | 31.51%14.55M | 11.17%13.61M | -10.57%8.38M | 71.34%12.74M |
Current liabilities | 43.05%321.4M | 43.05%321.4M | 35.91%314.02M | 70.17%324.81M | 217.89%198.65M | 156.22%224.68M | 156.22%224.68M | 162.55%231.06M | 134.01%190.88M | 4.74%62.49M |
Non current liabilities | ||||||||||
Long term provisions | 13.10%6.39M | 13.10%6.39M | 0.00%5.65M | 0.00%5.65M | 0.00%5.65M | 0.00%5.65M | 0.00%5.65M | 0.00%5.65M | 0.00%5.65M | --5.65M |
Other non current liabilities | ---- | ---- | 0.00%1K | 100.00%2K | --1K | ---- | ---- | --1K | 0.00%1K | ---- |
Total non current liabilities | 13.10%6.39M | 13.10%6.39M | 0.00%5.65M | 0.02%5.65M | 0.02%5.65M | 0.00%5.65M | 0.00%5.65M | 0.02%5.65M | 0.00%5.65M | 534.12%5.65M |
Total liabilities | 42.31%327.79M | 42.31%327.79M | 35.05%319.68M | 68.15%330.47M | 199.82%204.3M | 146.76%230.33M | 146.76%230.33M | 152.75%236.71M | 125.32%196.53M | 12.53%68.14M |
Shareholders'equity | ||||||||||
Share capital | 97.71%80.96M | 97.71%80.96M | 146.79%75.67M | 182.48%69.78M | -97.49%46.59M | -97.79%40.95M | -97.79%40.95M | -98.34%30.66M | -98.45%24.7M | 1,759.19%1.86B |
-common stock | 97.71%80.96M | 97.71%80.96M | 146.79%75.67M | 182.48%69.78M | -97.49%46.59M | -97.79%40.95M | -97.79%40.95M | -98.34%30.66M | -98.45%24.7M | 1,759.19%1.86B |
Additional paid-in capital | 0.74%5.42B | 0.74%5.42B | 0.84%5.42B | 0.84%5.41B | 53.30%5.39B | 53.41%5.38B | 53.41%5.38B | 53.41%5.37B | 65.29%5.37B | 100.18%3.52B |
Retained earnings | -63.53%-920.02M | -63.53%-920.02M | -84.81%-781.12M | 6.88%-654.01M | -17.19%-708.82M | -9.91%-562.61M | -9.91%-562.61M | 0.45%-422.67M | -91.63%-702.31M | -48.17%-604.85M |
Less: Treasury stock | --7K | --7K | --7K | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other equity interest | 117.97%20.18M | 117.97%20.18M | 91.66%13.69M | 157.55%13.77M | 250.00%11.68M | --9.26M | --9.26M | --7.15M | --5.35M | --3.34M |
Total stockholders'equity | -5.47%4.6B | -5.47%4.6B | -5.25%4.73B | 3.13%4.84B | -0.73%4.74B | 0.42%4.87B | 0.42%4.87B | 1.30%4.99B | 4.99%4.69B | 229.66%4.77B |
Total equity | -5.47%4.6B | -5.47%4.6B | -5.25%4.73B | 3.13%4.84B | -0.73%4.74B | 0.42%4.87B | 0.42%4.87B | 1.30%4.99B | 4.99%4.69B | 229.66%4.77B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |